updates on the smart stop trial: the potential for a chemo-free regimen in the frontline for dlbcl
Published 5 months ago • 112 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
0:34
an update on the majestec-1 trial: the efficacy of less frequent dosing of teclistamab in rrmm
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
1:51
checkpoint inhibition in the treatment of mpns
-
5:40
an update on the tap network
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
2:18
efficacy and safety results from the anchor trial
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:27
the promise of novel checkpoint inhibitors for the treatment of hl
-
0:42
upcoming trial updates in all
-
0:42
targeted therapies for dlbcl treatment